Flow cytometric detection of dyserythropoiesis: A sensitive and powerful diagnostic tool for myelodysplastic syndromes

Leukemia

Volumn 27, Issue 10, 2013, Pages 1981-1987

  Mathis, S ^a,b   Chapuis, N ^a,b   Debord, C ^a   Rouquette, A ^c   Radford Weiss, I ^d   Park, S ^a,b   Dreyfus, F ^a,b   Lacombe, C ^a,b   Bene M C ^a   Kosmider, O ^a,b   Fontenay, M ^a,b   Bardet, V ^a,b  

^a AP HP   (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

dyserythropoiesis; flow cytometry; myelodysplastic syndromes

Indexed keywords

CD36 ANTIGEN; CD71 ANTIGEN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BONE MARROW; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; CYTOPENIA; DIAGNOSTIC ACCURACY; DISEASE MARKER; DYSERYTHROPOIESIS; ERYTHROBLAST; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CASE-CONTROL STUDIES; ERYTHROBLASTS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, TRANSFERRIN; ROC CURVE; YOUNG ADULT;

EID: 84885610453     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.178     Document Type: Article

References (24)

1. WHO. Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. (International Agency for Research on Cancer. IARC): Lyon, France, 2008.
2. Valent P, Bain BJ, Bennett JM, Wimazal F, Sperr WR, Mufti G et al. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Leuk Res 2012; 36: 1-5.
3. Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P et al. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia 2012; 26: 1730-1741.
4. van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS et al. Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group. Leuk Lymphoma 2013; 54: 472-475.
5. Maynadie M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G et al. Immunophenotypic clustering of myelodysplastic syndromes. Blood 2002; 100: 2349-2356.
6. Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001; 98: 979-987.
7. Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 2005; 19: 776-783.
8. Della Porta MG, Malcovati L, Invernizzi R, Travaglino E, Pascutto C, Maffioli M et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 2006; 20: 549-555.
9. Matarraz S, Lopez A, Barrena S, Fernandez C, Jensen E, Flores-Montero J et al. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients. Cytometry 2010; 78: 154-168.
10. Xu F, Wu L, He Q, Zhang Z, Chang C, Li X. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes. Intern Med J 2012; 42: 401-411.
11. Chopra A, Pati H, Mahapatra M, Mishra P, Seth T, Kumar S et al. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches. Ann Hematol 2012; 91: 1351-1362.
12. Allan RW, Ansari-Lari MA, Jordan S. DRAQ5-based, no-lyse, no-wash bone marrow aspirate evaluation by flow cytometry. Am J Clin Pathol 2008; 129: 706-713.
13. Bjornsson S, Wahlstrom S, Norstrom E, Bernevi I, O'Neill U, Johansson E et al. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer. Cytometry 2008; 74: 91-103.
14. Edward R. Use of DNA-specific anthraquinone dyes to directly reveal cytoplasmic and nuclear boundaries in live and fixed cells. Mol Cells 2009; 27: 391-396.
15. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ 2002; 324: 539-541.
16. Holdrinet RS, von Egmond J, Wessels JM, Haanen C. A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp Hematol 1980 8:103-107.
17. Ogata K, Della Porta MG, Malcovati L, Picone C, Yokose N, Matsuda A et al. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. Haematologica 2009; 94: 1066-1074.
18. Della Porta MG, Picone C, Pascutto C, Malcovati L, Tamura H, Handa H et al. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study. Haematologica 2012; 97: 1209-1217.
19. Mitelman F. ISCN: An international system for human genetic nomenclature. S. Karger: Basel, Switzerland, 2013.
20. Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C et al. Clonal architecture of chronic myelomonocytic leukemias. Blood 2013; 121: 2186-2198.
21. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35.
22. Hosmer D, Lemeshow S. Applied Logistic Regression. John Wiley & Sons Inc: New York, NY, USA, 1989.
23. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454-2465.
24. Kern W, Haferlach C, Schnittger S, Alpermann T, Haferlach T. Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics. Haematologica 2013; 98: 201-207.